Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-30,300
Closed -$609K 4268
2019
Q4
$609K Buy
+30,300
New +$564K ﹤0.01% 3444
2018
Q2
Sell
-30,000
Closed -$1.24M 4157
2018
Q1
$1.24M Sell
30,000
-15,900
-35% -$678K ﹤0.01% 2814
2017
Q4
$1.94M Hold
45,900
﹤0.01% 2458
2017
Q3
$1.44M Buy
+45,900
New +$1.56M ﹤0.01% 2826
2016
Q1
Sell
-30,000
Closed -$1.62M 4321
2015
Q4
$1.62M Buy
+30,000
New +$1.44M ﹤0.01% 2434
2014
Q3
Sell
-19,700
Closed -$1.02M 4660
2014
Q2
$1.02M Hold
19,700
﹤0.01% 3270
2014
Q1
$962K Buy
+19,700
New +$957K ﹤0.01% 3156

Other funds holding VTRS

Credit Suisse's VTRS Position: Q1 2024 in Review

Credit Suisse reduced its Viatris (VTRS) stake by 21% in Q1 2024, selling an estimated $5.81M and leaving 1,779,687 shares worth $21.2M. The position accounts for 0.02% of the portfolio, ranked #617.

Credit Suisse first reported a position in VTRS in Q2 2013 and has held it in 44 quarters since. The position peaked at $188M in Q3 2016. 1,008 funds tracked by Wall St. Rank hold VTRS as of Q1 2024.

  • Credit Suisse held 1,779,687 shares of Viatris worth $21.2M as of Q1 2024.
  • Credit Suisse sold 482,714 Viatris shares in Q1 2024, an estimated $5.81M.
  • Viatris made up 0.02% of Credit Suisse's portfolio in Q1 2024, its #617 holding.
  • Credit Suisse first reported a position in Viatris in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Viatris position peaked at $188M in Q3 2016.
  • 1,008 funds tracked by Wall St. Rank held Viatris as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.